Ansaldo Eduard, Yong Daniel, Carrillo Nathan, McFadden Taryn, Abid Mahnoor, Corral Dan, Rivera Claudia, Farley Taylor, Bouladoux Nicolas, Gribonika Inta, Belkaid Yasmine
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
Intestinal immunity defends against enteric pathogens, mediates symbiotic relationships with the resident microbiota, and provides tolerance to food antigens, safeguarding critical nutrient absorption and barrier functions of this mucosal tissue. Despite the abundance of tissue resident activated T cells, their contributions to these various roles remains poorly understood. Here, we identify a dominant population of IL-10 producing, T-bet expressing CD4+ Tr1 T cells, residing in the small intestinal lamina propria at homeostasis. Remarkably, these intestinal Tr1 cells emerge at the time of weaning and accumulate independently of the microbiota displaying similar abundance, function and TCR repertoire under germ-free conditions. Instead, the small intestinal T-bet+ Tr1 program is driven and shaped by dietary antigens, and accumulates in a cDC1-IL-27 dependent manner. Upon activation, these cells robustly express IL-10 and multiple inhibitory receptors, establishing a distinct suppressive profile. Altogether, this work uncovers a previously unappreciated dominant player in homeostatic small intestinal immunity with the potential to play critical suppressive roles in this tissue, raising important implications for the understanding of immune regulation in the intestine.
Establishing immunological tolerance to self and environmental antigens is critical to preserve tissue homeostasis and function. In the intestine, both dietary and microbiota derived antigens are routinely encountered by the immune system, which deploys a variety of mechanisms to maintain tolerance to these innocuous antigens. Understanding how immunological tolerance is established is critical, a when this process goes awry it can lead to severe inflammatory and autoimmune diseases such as food allergy and inflammatory bowel disease. However, how tolerance is established in the intestine is still poorly understood. In this study we describe a novel dominant T cell population in the small intestine shaped by dietary components with the potential to play important roles in immune tolerance at this site. back # IntroductionBarrier surfaces such as the gut and skin represent the first line of defense against the environment. These organs must strike a delicate balance between providing protection against environmental and infectious agents, maintaining tissue function, and establishing a homeostatic symbiotic relationship with resident microbes collectively known as the microbiota (1). The immune system plays a critical role in establishing these dynamic and carefully regulated relationships, as evidenced by the large number of immune cells present at these sites. Of particular note, activated T cells are very abundant at barrier tissues, where they orchestrate immune effector functions geared towards these varied tasks (1, 2). In the small intestine, the intraepithelial compartment harbors innate like natural CD8aa⁺ IELs, many of which are self reactive; as well as CD4⁺CD8aa⁺ and CD8ab⁺ IELs responding to dietary and microbial antigens (3). The underlying lamina propria (SILP) harbors predominantly CD4⁺ T cells, which participate in responses to commensal-derived and dietary antigens (2, 4). Despite the abundance of small intestinal CD4 T cells, only a handful of cognate immune interactions focusing on Type 17 and T regulatory helper subsets have been described. Thus, whether immune responses in this tissue are truly limited to a small number of antigenic triggers and effector functions remains to be fully elucidated. The small number of gut homeostatic CD4 T cell responses described thus far have been shown to primarily respond to specific commensal bacteria or dietary antigens (1, 2, 5-8): Among other examples, SFB induces cognate Th17 cells in the small intestine (9, 10), a consortium human commensal bacteria induces CD8b⁺ cells in the colon (11), and indices T and other effector cells in the Peyer's patches and lamina propria, respectively (12). Furthermore most regulatory T cells in the colon are induced in response to commensal or pathobiont species at homeostasis, providing critical regulatory functions (13, 14). Cognate immune responses to SFB help contain this commensal species in the intestine (15), but also have systemic impacts on the susceptibility to autoimmune disease (16, 17). Interestingly, despite presenting a classical Th17 effector profile, a subset of SFB-induced Th17 cells possess IL-10 secretion capabilities and suppress cognate immune responses without the expression of Foxp3 (18), suggesting immunoregulatory functions reminiscent of Tr1 cells. Whether these competing capabilities are unique to SFB-specific immune responses or a general hallmark of small intestinal immunity remains unknown. The description of SFB-specific Tr1-like cells in the small intestine was surprising, as this CD4⁺ T cell subset, characterized by abundant IL-10 secretion in the absence of expression, has only been described in the context of chronic antigen stimulation, such as chronic infection or cancer (19). The Tr1 cell program is controlled by a variety of transcription factors and upstream signaling pathways, including IL-27 signaling, MAF and AHR (20). AHR-ligands are abundant in the intestine, and MAF is a hallmark of other regulatory commensal-specific responses (21, 14). Furthermore, IL-27, which can induce both proinflammatory and immunoregulatory functions, is abundant in the small intestine (22, 23). This raises the possibility that the Tr1 program is a more general feature of small intestinal immunity, not uniquely restricted to SFB-specific responses. In this study we explore the breadth of CD4⁺ T cell responses in the small intestine, and uncover a previously uncharacterized CD4⁺T-bet⁺ T cell immune response that is dominant in this tissue. Unexpectedly, these SILP CD4⁺T-bet⁺ T cells are independent of the microbiota, maintaining a similar functional profile and shared antigen specificities in germ-free conditions. Instead, we reveal that dietary components drive the accumulation, function, and clonal selection of this T cell population. Finally, we show that, contrary to classical Th1 cells, SILP CD4⁺T-bet⁺ T cells adopt a Tr1 immunoregulatory functional program during activation, suggesting that this is a general feature of CD4⁺ T cell immunity in the small intestine wired towards immune regulation and tissue homeostasis.
肠道免疫可抵御肠道病原体,介导与常驻微生物群的共生关系,并对食物抗原产生耐受性,从而保障该黏膜组织的关键营养吸收和屏障功能。尽管组织驻留的活化T细胞数量众多,但它们在这些不同作用中的贡献仍知之甚少。在这里,我们鉴定出一群主要产生白细胞介素-10(IL-10)、表达T-bet的CD4⁺Tr1 T细胞,它们在稳态下存在于小肠固有层中。值得注意的是,这些肠道Tr1细胞在断奶时出现,并在无菌条件下独立于微生物群积累,表现出相似的丰度、功能和TCR库。相反,小肠T-bet⁺Tr1程序由饮食抗原驱动和塑造,并以cDC1-IL-27依赖的方式积累。激活后,这些细胞强烈表达IL-10和多种抑制性受体,形成独特的抑制特征。总之,这项工作揭示了稳态小肠免疫中一个以前未被重视的主要参与者,它有可能在该组织中发挥关键的抑制作用,这对理解肠道免疫调节具有重要意义。
建立对自身和环境抗原的免疫耐受性对于维持组织稳态和功能至关重要。在肠道中,免疫系统经常会遇到饮食和微生物群衍生的抗原,它会部署多种机制来维持对这些无害抗原的耐受性。了解免疫耐受性是如何建立的至关重要,因为当这个过程出错时,可能会导致严重的炎症和自身免疫性疾病,如食物过敏和炎症性肠病。然而,肠道中耐受性是如何建立的仍知之甚少。在这项研究中,我们描述了一种由饮食成分塑造的小肠中新型主要T细胞群体,它有可能在该部位的免疫耐受中发挥重要作用。# 引言
肠道和皮肤等屏障表面是抵御外界环境的第一道防线。这些器官必须在提供针对环境和感染因子的保护、维持组织功能以及与被称为微生物群的常驻微生物建立稳态共生关系之间取得微妙的平衡(1)。免疫系统在建立这些动态且受到严格调控的关系中起着关键作用,这些部位存在大量免疫细胞就证明了这一点。特别值得注意的是,活化的T细胞在屏障组织中非常丰富,它们在这些部位协调针对各种任务的免疫效应功能(1, 2)。在小肠中,上皮内隔室含有天然的CD8aa⁺ IELs样固有免疫细胞,其中许多是自身反应性的;还有对饮食和微生物抗原作出反应的CD4⁺CD8aa⁺和CD8ab⁺ IELs(3)。下方的固有层(SILP)主要含有CD4⁺ T细胞,它们参与对共生菌衍生和饮食抗原的反应(2, 4)。尽管小肠中CD4 T细胞数量众多,但仅描述了少数针对17型和调节性辅助亚群的同源免疫相互作用。因此,该组织中的免疫反应是否真的仅限于少数抗原触发因素和效应功能仍有待充分阐明。迄今为止描述的少数肠道稳态CD4 T细胞反应已被证明主要对特定的共生细菌或饮食抗原作出反应(1, 2, 5 - 8):例如,分段丝状细菌(SFB)在小肠中诱导同源的Th17细胞(9, 10),一组人类共生细菌在结肠中诱导CD8b⁺细胞(11),以及分别在派尔集合淋巴结和固有层中诱导T细胞和其他效应细胞(12)。此外,结肠中的大多数调节性T细胞是在稳态下对共生菌或致病共生菌作出反应时诱导产生的,提供关键的调节功能(13, 14)。对SFB的同源免疫反应有助于在肠道中控制这种共生菌(15),但也对自身免疫性疾病的易感性产生全身性影响(16, 17)。有趣的是,尽管呈现出经典的Th17效应特征,但SFB诱导的Th17细胞亚群具有分泌IL-10的能力,并且在不表达Foxp3的情况下抑制同源免疫反应(18),这表明其具有类似于Tr1细胞的免疫调节功能。这些相互竞争的能力是SFB特异性免疫反应所特有的,还是小肠免疫的一般特征,仍然未知。小肠中SFB特异性Tr1样细胞的描述令人惊讶,因为这种CD4⁺ T细胞亚群,其特征是在不表达Foxp3的情况下大量分泌IL-10,仅在慢性抗原刺激的背景下被描述过,如慢性感染或癌症(19)。Tr1细胞程序受多种转录因子和上游信号通路控制,包括IL-27信号通路、MAF和芳香烃受体(AHR)(20)。AHR配体在肠道中丰富,MAF是其他调节性共生菌特异性反应的标志(21, 14)。此外,IL-27既能诱导促炎功能,也能诱导免疫调节功能,在小肠中含量丰富(22, 23)。这就提出了一种可能性,即Tr1程序是小肠免疫的更普遍特征,并非仅局限于SFB特异性反应。在这项研究中,我们探索了小肠中CD4⁺ T细胞反应的广度,并发现了一种以前未被表征的CD4⁺T-bet⁺ T细胞免疫反应,它在该组织中占主导地位。出乎意料的是,这些SILP CD4⁺T-bet⁺ T细胞独立于微生物群,在无菌条件下保持相似的功能特征和共享的抗原特异性。相反,我们发现饮食成分驱动了这群T细胞的积累、功能和克隆选择。最后,我们表明,与经典的Th1细胞相反,SILP CD4⁺T-bet⁺ T细胞在激活过程中采用Tr1免疫调节功能程序,这表明这是小肠中CD4⁺ T细胞免疫朝向免疫调节和组织稳态的一个普遍特征。